Myocardial CD36 expression and fatty acid accumulation in patients with type I and II CD36 deficiency

…, K Toba, Y Ogawa, H Hanawa, Y Hirokawa… - Annals of nuclear …, 1998 - Springer
Long-chain fatty acids (LCFA) are one of the major cardiac energy substrates, so understanding
LCFA metabolism may help in elucidating the mechanisms of various heart diseases. …

Myocardial sympathetic denervation, fatty acid metabolism, and left ventricular wall motion in vasospastic angina

…, T Takahashi, S Miyajima, Y Hirokawa… - Journal of Nuclear …, 2002 - Soc Nuclear Med
Although various noninvasive methods have been used to detect vasospasm, none of them
are sensitive enough for patients with sporadic attacks. Because abnormal fatty acid …

Abnormal fatty acid metabolism in patients with coronary vasospasm

…, Y Aizawa, N Tanabe, K Kato, Y Hirokawa… - Annals of nuclear …, 1999 - Springer
Although various noninvasive methods have been used to detect vasospasm, none of them
are sensitive enough for patients with sporadic attacks. Since abnormal fatty acid …

Different patterns of 123I-BMIPP myocardial accumulation in patients with type I and II CD36 deficiency

…, Y Kusano, T Nagatomo, Y Hirokawa - Kaku igaku. The …, 1997 - europepmc.org
The CD36 molecule is a multifunctional membrane type receptor glycoprotein that reacts with
thrombospondin, collagen, oxidized LDL and long-chain fatty acids (LCFA). LCFA are one …

-242-ACUTE AND CHRONIC EFFECTS OF XAMOTEROL (CORWIN) IN IDIOPATHIC DILATED CARDIOMYOPATHY

K Watanabe, Y Hirokawa, A Yokoyama… - Japanese Circulation …, 1986 - jstage.jst.go.jp
… Kenichi Watanabe, Yoichi Hirokawa, Akihiro Yokoyama, Hirotaka Oda, Hideaki Ohtsuka,
Kazuo Maeda, Tsuneo Nagai, Takashi Tsuda, Senji Hayashi, Yoshimitsu Yazawa, Yutaka …

Sustained Ventricular Tachycardia Responsive to Verapamil in Patients with Hypertrophic Cardiomyopathy Clinical and Electrophysiological Assessment of Drug …

…, K EBE, T FUJITA, J ISHIGURO, Y HIROKAWA… - Japanese heart …, 1989 - jstage.jst.go.jp
Recently, we examined 2 cases of hypertrophic cardiomyopathy (HCM) presenting with
sustained ventricular tachycardia (VT). One case was a 62 year old male with midventricular …

A case of giant cell myocarditis with evidence of cardiac autoimmunity

…, T Izumi, A Shibata, T Yamamoto, Y Hirokawa… - Cardiovascular …, 1995 - Elsevier
A 45-year-old-woman with giant cell myocarditis showing high titer of circulating antiheart
antibodies is reported. She experienced two recurrences of myocarditis and repeatedly …

Acute and chronic effects of xamoterol in idiopathic dilated cardiomyopathy

K WATANABE, Y HIROKAWA, K SUZUKI… - Japanese heart …, 1988 - jstage.jst.go.jp
Xamoterol, a ƒÀ1-partial agonist, was given to 10 patients with idiopathic dilated cardiomyopathy
in NYHA functional classes II and III. The acute and chronic effects of xamoterol were …

Effects of Daisaiko-to, Choto-san and Sairei-to in spontaneously hypertensive rats

K WATANABE, Y HIROKAWA, A SHIBATA… - … /Japanese Journal of …, 1987 - jstage.jst.go.jp
In spontaneously hypertensive rats (SHR), blood pressure, heart weight and cardiac
norepinephrine concentration were significantly increased at 16 weeks of age in comparison with …

Long-term effect of xamoterol in patients with dilated cardiomyopathy

K WATANABE, Y HIROKAWA… - Rinsho yakuri/Japanese …, 1989 - jstage.jst.go.jp
Dilated cardiomyopathy (DCM) is a disease of unknown etiology which is characterised by
left ventricular dilation and reduced contractility. The prognosis is variable but generally poor, …